FRANKFURT, Jan 25 (Reuters) - AstraZeneca on Monday
described German media reports saying its COVID-19 vaccine was
shown to have a very low efficacy in the elderly as "completely
incorrect".
German daily papers Handelsblatt and Bild said in separate
reports on Monday the vaccine - co-developed by AstraZeneca and
Oxford University - had an efficacy of 8% or less than 10%,
respectively, in those over 65 and the German government did not
expect the European regulator to approve the product for that
age group.
(Reporting by Ludwig Burger)